 Mice, Nude
"Mice, Nude" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.
| Descriptor ID |
D008819
|
| MeSH Number(s) |
B01.050.150.900.649.313.992.635.505.500.550.500
|
| Concept/Terms |
Mice, Nude- Mice, Nude
- Athymic Mice
- Mouse, Nude
- Nude Mouse
- Nude Mice
- Mouse, Athymic
- Athymic Mouse
- Mice, Athymic
|
Below are MeSH descriptors whose meaning is more general than "Mice, Nude".
Below are MeSH descriptors whose meaning is more specific than "Mice, Nude".
This graph shows the total number of publications written about "Mice, Nude" by people in this website by year, and whether "Mice, Nude" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 3 | 4 | | 1995 | 0 | 3 | 3 | | 1996 | 0 | 5 | 5 | | 1997 | 0 | 1 | 1 | | 1998 | 0 | 3 | 3 | | 1999 | 0 | 5 | 5 | | 2000 | 0 | 3 | 3 | | 2001 | 0 | 2 | 2 | | 2002 | 0 | 7 | 7 | | 2003 | 0 | 5 | 5 | | 2004 | 0 | 9 | 9 | | 2005 | 0 | 9 | 9 | | 2006 | 0 | 14 | 14 | | 2007 | 0 | 7 | 7 | | 2008 | 0 | 15 | 15 | | 2009 | 0 | 21 | 21 | | 2010 | 0 | 16 | 16 | | 2011 | 0 | 21 | 21 | | 2012 | 0 | 25 | 25 | | 2013 | 0 | 27 | 27 | | 2014 | 0 | 26 | 26 | | 2015 | 0 | 18 | 18 | | 2016 | 0 | 15 | 15 | | 2017 | 0 | 20 | 20 | | 2018 | 0 | 14 | 14 | | 2019 | 0 | 10 | 10 | | 2020 | 0 | 15 | 15 | | 2021 | 0 | 9 | 9 | | 2022 | 0 | 3 | 3 | | 2023 | 0 | 1 | 1 | | 2024 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Mice, Nude" by people in Profiles.
-
Yadav M, Kandhari K, Mathan SV, Ali M, Singh RP. Fisetin induces G2/M phase arrest and caspase-mediated cleavage of p21Cip1 and p27Kip1 leading to apoptosis and tumor growth inhibition in HNSCC. Mol Carcinog. 2024 Sep; 63(9):1697-1711.
-
Pires EM, Pugazhenthi U, Fink MK, Habenicht LM, Fong DL, Leszczynski JK, Schurr MJ, Manuel CA. Antibiotic Treatment of Corynebacterium bovis-associated Clinical Disease in NSG Mice. Comp Med. 2023 Dec 01; 73(6):461-465.
-
Manuel CA, Pearson EC, Pugazhenthi U, Fink MK, Habenicht LM, Fong DL, Leszczynski JK, Schurr MJ. A Clinical Scoring Systems for the Evaluation of Corynebacterium bovis -associated Disease in NSG Mice. Comp Med. 2022 12 01; 72(6):386-393.
-
Roy S, Curry SD, Corbella Bagot C, Mueller EN, Mansouri AM, Park W, Cha JN, Goodwin AP. Enzyme Prodrug Therapy with Photo-Cross-Linkable Anti-EGFR Affibodies Conjugated to Upconverting Nanoparticles. ACS Nano. 2022 10 25; 16(10):15873-15883.
-
Manuel CA, Johnson LK, Pugazhenthi U, Fong DL, Fink M, Habenicht LM, Leszczynski JK, Diana IR, Schurr MJ, Frank DN. Effect of Antimicrobial Prophylaxis on Corynebacterium bovis Infection and the Skin Microbiome of Immunodeficient Mice. Comp Med. 2022 04 01; 72(2):78-89.
-
Kurth I, Yamaguchi N, Andreu-Agullo C, Tian HS, Sridhar S, Takeda S, Gonsalves FC, Loo JM, Barlas A, Manova-Todorova K, Busby R, Bendell JC, Strauss J, Fakih M, McRee AJ, Hendifar AE, Rosen LS, Cercek A, Wasserman R, Szarek M, Spector SL, Raza S, Tavazoie MF, Tavazoie SF. Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels. Sci Adv. 2021 10 08; 7(41):eabi7511.
-
Smith BD, Kaufman MD, Wise SC, Ahn YM, Caldwell TM, Leary CB, Lu WP, Tan G, Vogeti L, Vogeti S, Wilky BA, Davis LE, Sharma M, Ruiz-Soto R, Flynn DL. Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages. Mol Cancer Ther. 2021 11; 20(11):2098-2109.
-
Kwon M, Rubio G, Nolan N, Auteri P, Volmar JA, Adem A, Javidian P, Zhou Z, Verzi MP, Pine SR, Libutti SK. FILIP1L Loss Is a Driver of Aggressive Mucinous Colorectal Adenocarcinoma and Mediates Cytokinesis Defects through PFDN1. Cancer Res. 2021 11 01; 81(21):5523-5539.
-
Gartrell J, Mellado-Largarde M, Clay MR, Bahrami A, Sahr NA, Sykes A, Blankenship K, Hoffmann L, Xie J, Cho HP, Twarog N, Connelly M, Yan KK, Yu J, Porter SN, Pruett-Miller SM, Neale G, Tinkle CL, Federico SM, Stewart EA, Shelat AA. SLFN11 is Widely Expressed in Pediatric Sarcoma and Induces Variable Sensitization to Replicative Stress Caused By DNA-Damaging Agents. Mol Cancer Ther. 2021 11; 20(11):2151-2165.
-
Nassar KW, Hintzsche JD, Bagby SM, Espinoza V, Langou?t-Astri? C, Amato CM, Chimed TS, Fujita M, Robinson W, Tan AC, Schweppe RE. Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor-Resistant Melanoma. Mol Cancer Ther. 2021 10; 20(10):2049-2060.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|